Australia markets close in 2 hours 53 minutes

iBio, Inc. (IBIO)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.5150+0.0225 (+4.57%)
At close: 04:00PM EST
0.5000 -0.01 (-2.91%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.4925
Open0.4913
Bid0.5000 x 1400
Ask0.5150 x 800
Day's range0.4810 - 0.5150
52-week range0.4800 - 2.8300
Volume1,382,787
Avg. volume3,638,276
Market cap112.248M
Beta (5Y monthly)-6.02
PE ratio (TTM)N/A
EPS (TTM)-0.1190
Earnings date14 Feb 2022 - 18 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.25
  • GlobeNewswire

    iBio Announces Participation in the H.C. Wainwright BioConnect Conference

    BRYAN, Texas, Jan. 04, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced that it will participate in the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022. iBio's pre-recorded presentation will be available on demand during the event for all registered attendees. Beginning on Monday, January 10, 2

  • GlobeNewswire

    iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022

    - Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -BRYAN, Texas, Dec. 22, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced that it has adjourned its 2021 Annual Meeting of Shareholders (the “Annual Meeting”) with respect to Proposals 4 and 5. The Company partially adjourned the

  • GlobeNewswire

    iBio Provides Information for Listening to the Virtual Annual Stockholder Meeting

    BRYAN, Texas, Dec. 21, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, provides the following link to listen virtually to the 2021 Annual Shareholders meeting: www.virtualshareholdermeeting.com/IBIO2021. The meeting will be held at 9:00 AM EST on December 22, 2021. iBio had partially adjourned the 2021 Annual Stockholder meeting related to